urea has been researched along with 8,11,14-eicosatrienoic acid in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Draper, AJ; Engler, MM; Graham, L; Hammock, BD; Huse, LM; Kroetz, DL; Morisseau, C; Newman, JW; Parker, C; Xu, F; Yu, Z; Zeldin, DC | 1 |
| Fang, X; Hammock, BD; Hu, S; Liu, Y; Shyy, JY; Snyder, GD; Spector, AA; Watanabe, T; Weintraub, NL; Yao, J | 1 |
| Falck, JR; Fang, X; Harmon, S; Hu, S; Liu, Y; Sangras, B; Snyder, GD; Spector, AA; Weintraub, NL; Xu, B; Yao, J | 1 |
| Falck, JR; Hammock, BD; Kroetz, DL; Morisseau, C; Ng, VY | 1 |
| Chiang, PC; Fujiwara, H; Ghosh, S; Roberds, SL; Selbo, JG; Wahlstrom, JL | 1 |
| Alkayed, NJ; Cao, Z; Iliff, J; Liu, L; Merkel, MJ; Motoki, A; Packwood, WH; Van Winkle, DM | 1 |
| Benter, IF; Roman, RJ; Yousif, MH | 1 |
| Alonso-Galicia, M; Berger, JP; Chen, HS; Chen, Y; Colletti, SL; Deng, Q; Ding, FX; Pai, LY; Roy, S; Shen, HC; Tata, JR; Tong, V; Tong, X; Xu, S; Zhang, B; Zhang, X; Zhou, G | 1 |
| Campbell, WB; Falck, JR; Gauthier, KM; Gutterman, DD; Harder, A; Imig, JD; Isbell, M; Olson, L | 1 |
| Albadine, R; Morin, C; Rousseau, E; Senouvo, FY; Sirois, C; Tabet, Y | 1 |
| Falck, JR; Morisseau, C; Mustafa, SJ; Nayeem, MA; Pradhan, I; Zeldin, DC | 1 |
| Alkayed, NJ; Jouihan, SA; Krasnow, SM; Marks, DL; Shangraw, RE; Zhang, W; Zuloaga, KL | 1 |
| Alkayed, NJ; Chadderdon, S; Davidson, BP; Kim, S; Lindner, JR; Qi, Y; Shim, CY; Wu, M; Xie, A | 1 |
| Bürgelová, M; Červenka, L; Hammock, BD; Husková, Z; Hwang, SH; Imig, JD; Melenovský, V; Sadowski, J; Škaroupková, P; Sporková, A | 1 |
14 other study(ies) available for urea and 8,11,14-eicosatrienoic acid
| Article | Year |
|---|---|
Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acids; Blood Pressure; Cytosol; Eicosanoids; Enzyme Inhibitors; Epoxide Hydrolases; Epoxy Compounds; Hydrolysis; Hypertension; Kidney Cortex; Male; Microsomes; Microsomes, Liver; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Species Specificity; Urea | 2000 |
Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Binding, Competitive; Biotransformation; Blotting, Western; Carnitine O-Palmitoyltransferase; Cell Movement; Chlorocebus aethiops; COS Cells; Cyclohexanes; Enzyme Inhibitors; Epoxide Hydrolases; Lauric Acids; Ligands; Mice; PPAR alpha; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA; Transfection; Urea | 2005 |
14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acids; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Epoxide Hydrolases; Epoxy Compounds; Humans; PPAR alpha; Urea | 2006 |
Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor alpha-dependent repression of cyclin D1.
Topics: 8,11,14-Eicosatrienoic Acid; Cell Line; Cell Proliferation; Cyclin D1; Eicosanoids; Epoxide Hydrolases; Fatty Acids; Gene Expression; Gene Expression Regulation; Humans; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Peroxisome Proliferators; Platelet-Derived Growth Factor; PPAR alpha; Response Elements; Urea | 2006 |
Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats.
Topics: 8,11,14-Eicosatrienoic Acid; Administration, Oral; Animals; Blood Pressure; Chromatography, Liquid; Disease Models, Animal; Epoxide Hydrolases; Hypertension; Male; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley; Solubility; Suspensions; Tandem Mass Spectrometry; Urea | 2008 |
Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Disease Models, Animal; Enzyme Inhibitors; Epoxide Hydrolases; Female; Gene Deletion; Heart Ventricles; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Time Factors; Urea | 2008 |
Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury.
Topics: 8,11,14-Eicosatrienoic Acid; Amidines; Animals; Arachidonic Acid; Blood Glucose; Body Weight; Coronary Circulation; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Epoxide Hydrolases; Glyburide; Heart; Hydroxyeicosatetraenoic Acids; Male; Microsomes; Myocardium; Rats; Rats, Wistar; Reperfusion Injury; Urea; Vascular Resistance; Ventricular Dysfunction, Left | 2009 |
Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Blood Pressure; Epoxide Hydrolases; Humans; Hypertension; Models, Molecular; Piperidines; Protein Binding; Rats; Rats, Inbred SHR; Structure-Activity Relationship; Urea | 2009 |
Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.
Topics: 8,11,14-Eicosatrienoic Acid; Amitrole; Animals; Arterioles; Benzoates; Catalase; Cattle; Drug Contamination; Enzyme Inhibitors; Epoxide Hydrolases; Kidney; Rats; Urea; Vasodilation; Vasodilator Agents | 2011 |
Improved bioavailability of epoxyeicosatrienoic acids reduces TP-receptor agonist-induced tension in human bronchi.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Benzoates; Blotting, Western; Bronchi; Cells, Cultured; Eicosapentaenoic Acid; Electrophoresis, Polyacrylamide Gel; Epoxide Hydrolases; Epoxy Compounds; Fluorescent Antibody Technique; Guinea Pigs; Humans; Mice; Muscle Tonus; Muscle, Smooth; Myocytes, Smooth Muscle; Rats; Receptors, Prostaglandin E; Receptors, Thromboxane; Signal Transduction; Thromboxane A2; Urea | 2011 |
Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine-5'-(N-ethylcarboxamide); Animals; Benzamides; Benzoates; Butyrates; Enzyme Inhibitors; Epoxide Hydrolases; Female; Gene Silencing; Lauric Acids; Male; Mice; NG-Nitroarginine Methyl Ester; Oxygenases; Phenethylamines; Phenylurea Compounds; PPAR gamma; Pyridines; Pyrimidines; Receptor, Adenosine A2A; Triazines; Triazoles; Urea; Vasodilation; Vasodilator Agents | 2013 |
Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Benzoates; Blood Glucose; Cerebral Angiography; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Epoxide Hydrolases; Male; Mice; Mice, Inbred C57BL; Optical Imaging; Real-Time Polymerase Chain Reaction; Streptozocin; Stroke; Up-Regulation; Urea | 2013 |
Epoxyeicosatrienoic acids mediate insulin-mediated augmentation in skeletal muscle perfusion and blood volume.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Benzoates; Blood Volume; Epoxide Hydrolases; Hyperinsulinism; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microcirculation; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Urea | 2014 |
Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzoates; Disease Models, Animal; Drug Evaluation, Preclinical; Epoxide Hydrolases; Epoxy Compounds; Heart Failure; Kidney; Male; Myocardium; Peptide Fragments; Random Allocation; Rats; Renal Insufficiency; Renin-Angiotensin System; Ultrasonography; Urea | 2015 |